Inventor · disambiguated record
Barbara Bertani
Also filed as: BERTANI BARBARA
19 granted patents·7 pending applications·36 citations·filing 1996–2023
91Inventor score
Files withBERTANI BARBARA6BOEHRINGER INGELHEIM INT6GLAXO GROUP LTD6CHIESI FARM SPA3GIOVANNINI RICCARDO3
Top patents by PatentIndex Score
26 records- 0189US10875867B2Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamideBOEHRINGER INGELHEIM INT·Filed 2019·Granted Dec 29, 2020·3 cites·13 claims
- 0284US12351584B2Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamideBOEHRINGER INGELHEIM INT·Filed 2023·Granted Jul 8, 2025·0 cites·13 claims
- 0384US10479794B2Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamideBOEHRINGER INGELHEIM INT·Filed 2018·Granted Nov 19, 2019·3 cites·73 claims
- 0482US11780827B2Substituted 3-phenoxyazetidin-1-yl-pyrazinesBOEHRINGER INGELHEIM INT·Filed 2021·Granted Oct 10, 2023·1 cites·11 claims
- 0579US7727988B2Azabicyclo[3.1.0]hex-3-yl}alkyl)pyrimidinedioneGLAXO GROUP LTD·Filed 2007·Granted Jun 1, 2010·5 cites·6 claims
- 0677US9085584B2Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disordersGIOVANNINI RICCARDO·Filed 2013·Granted Jul 21, 2015·5 cites·34 claims
- 0775US10023575B2Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamideBOEHRINGER INGELHEIM INT·Filed 2016·Granted Jul 17, 2018·1 cites·75 claims
- 0872US11691977B2Cyclic ether derivatives of pyrazolo[1,5-A]pyrimidine-3-carboxyamideBOEHRINGER INGELHEIM INT·Filed 2020·Granted Jul 4, 2023·0 cites·15 claims
- 0972US9012489B2Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicamentGIOVANNINI RICCARDO·Filed 2012·Granted Apr 21, 2015·2 cites·47 claims
- 1072US7592346B2Quinoline and quinazoline derivatives having affinity for 5HT1-type receptorsGLAXO GROUP LTD·Filed 2008·Granted Sep 22, 2009·1 cites·25 claims
- 1166US7732600B2Quinoline and quinazoline derivatives having affinity for 5HT1-type receptorsGLAXO GROUP LTD·Filed 2009·Granted Jun 8, 2010·0 cites·4 claims
- 1256US5977136ATetrahydroquinolines as NMDA antagonistsGLAXO WELLCOME SPA·Filed 1996·Granted Nov 2, 1999·15 cites·16 claims
- 1354US2009076274A1Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disordersGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 1451US2010204273A1Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type ReceptorsGLAXO GROUP LTD·Filed 2010·Application pending·0 cites
- 1550US8030322B2Spirocompounds useful as modulators for dopamine D3 receptorsGLAXO GROUP LTD·Filed 2007·Granted Oct 4, 2011·0 cites·5 claims
- 1647US2014045856A14-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenesGIOVANNINI RICCARDO·Filed 2013·Application pending·0 cites
- 1747US2024116948A1Pyrido oxazine derivatives as alk5 inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1846US8217168B2Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine D3 receptorsBERTANI BARBARA·Filed 2008·Granted Jul 10, 2012·0 cites·4 claims
- 1944US12479826B2Pyridazinyl amino derivatives as ALK5 inhibitorsCHIESI FARM SPA·Filed 2021·Granted Nov 25, 2025·0 cites·14 claims
- 2044US2024190891A1Pyrido oxazine amino derivatives as alk5 inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 2144US2006264429A1Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disordersBERTANI BARBARA·Filed 2003·Application pending·0 cites
- 2243US8163927B2Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptorsBERTANI BARBARA·Filed 2007·Granted Apr 24, 2012·0 cites·5 claims
- 2342US8222266B2Azabicyclo [3.1.0] hexyl derivatives as modulators of dopamine D3 receptorsBERTANI BARBARA·Filed 2007·Granted Jul 17, 2012·0 cites·7 claims
- 2440US11660293B2Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonistsCHRONOS THERAPEUTICS LTD·Filed 2018·Granted May 30, 2023·0 cites·20 claims
- 2540US8178549B2Azabicyclo [3. 1. O] hexyl derivatives as modulators of dopamine D3 receptorsBERTANI BARBARA·Filed 2008·Granted May 15, 2012·0 cites·2 claims
- 2639US2010004452A15-quinolinone derivatives as 5ht1a receptor modulators for treating sexual dysfunction, cognition impairment, psychotic disorders, anxiety, depression, etc.BERTANI BARBARA·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Barbara Bertani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →